Search

everythinglearnresearchcommunity

for

Search:↓

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Tph cells are linked to the severity of systemic lupus erythematosus.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

The new assay can track and measure melanosome transfer between skin cells, confirming filopodia's role in this process.

Lhx2 is essential for effective Sonic Hedgehog signaling in early retinal development.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Adding a second method to PROTACs could improve cancer treatment.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Biomimetic nanovesicles can speed up diabetic wound healing by regulating immune cell behavior and metabolism.

Removing the liver tumor improved the patient's skin condition and hair growth.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

The assay effectively identifies compounds that affect immune cell activation.

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.